Company Adynxx, Inc. Other OTC
Equities
ADYX
US00784D1037
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Julien Mamet
FOU | Founder | - | 30/09/07 |
Rick Orr
CEO | Chief Executive Officer | - | 30/11/10 |
Dina Gonzalez
DFI | Director of Finance/CFO | - | 31/12/09 |
William Martin
PRN | Corporate Officer/Principal | - | 31/12/11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eckard Weber
BRD | Director/Board Member | 73 | - |
Stanley Abel
BRD | Director/Board Member | - | 31/12/07 |
Dennis Podlesak
CHM | Chairman | 66 | - |
Rick Orr
CEO | Chief Executive Officer | - | 30/11/10 |
Matthew Ruth
BRD | Director/Board Member | - | 05/05/19 |
Julien Mamet
FOU | Founder | - | 30/09/07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,807,877 | 5,807,877 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Adynxx, Inc.
100 Pine Street Suite 500
94111, San Francisco
+
Sector
1st Jan change | Capi. | |
---|---|---|
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |